KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Merck (MRK) Operating Income (2016 - 2026)

Merck has reported Operating Income over the past 18 years, most recently at -$7.7 billion for Q1 2026.

  • Quarterly Operating Income fell 411.15% to -$7.7 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$5.5 billion through Mar 2026, down 208.46% year-over-year, with the annual reading at $4.7 billion for FY2025, 1.22% down from the prior year.
  • Operating Income was -$7.7 billion for Q1 2026 at Merck, down from -$2.1 billion in the prior quarter.
  • Over five years, Operating Income peaked at $2.9 billion in Q3 2025 and troughed at -$9.4 billion in Q2 2023.
  • The 5-year median for Operating Income is $10.0 million (2024), against an average of -$794.4 million.
  • Year-over-year, Operating Income crashed 3553.51% in 2023 and then skyrocketed 28800.0% in 2025.
  • A 5-year view of Operating Income shows it stood at -$368.0 million in 2022, then crashed by 1519.02% to -$6.0 billion in 2023, then skyrocketed by 105.74% to $342.0 million in 2024, then plummeted by 723.1% to -$2.1 billion in 2025, then tumbled by 262.69% to -$7.7 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Operating Income are -$7.7 billion (Q1 2026), -$2.1 billion (Q4 2025), and $2.9 billion (Q3 2025).